Ovid Therapeutics Inc. (OVID)
NASDAQ·Healthcare·Biotechnology
$2.42
+2.54%
Mkt Cap $298.06M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
Implied Upside
+127.3%
Consensus $5.50 vs current $2.42
NASDAQ·Healthcare·Biotechnology
$2.42
+2.54%
Mkt Cap $298.06M
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
+127.3%
Consensus $5.50 vs current $2.42